City
Epaper

US Congressman Krishnamoorthi calls on Biden admin to release AstraZeneca vaccine doses to hardest-hit countries including India

By ANI | Updated: April 26, 2021 00:05 IST

Indian-American Congressman Raja Krishnamoorthi on Saturday (local time) called on US President Joe Biden's administration to release doses of the AstraZeneca vaccine to countries currently experiencing massive and deadly surges in the spread of COVID-19, including India.

Open in App

Indian-American Congressman Raja Krishnamoorthi on Saturday (local time) called on US President Joe Biden's administration to release doses of the AstraZeneca vaccine to countries currently experiencing massive and deadly surges in the spread of COVID-19, including India.

"We are currently sitting on close to 40 million doses of the AstraZeneca vaccine in the US stockpile, a stockpile which we're not using and which we've already opened to combat COVID 19 in Mexico and Canada," Krishnamoorthi said in a statement.

"In order to curb the spread of this virus internationally and to protect public health and our international economy, we need to get these vaccines out the door now. I respectfully but strongly call on the Biden Administration to release millions of AstraZeneca vaccine doses to countries hardest-hit by the spread of COVID-19, including India, Argentina, and potentially others," he added.

India on Saturday recorded 3,46,786 new COVID-19 cases, the highest single-day spike since the pandemic broke out last year. According to the official data issued by the government, the country recorded 2,624 new deaths due to COVID-19 in the last 24 hours.

So far, 1,66,10,481 COVID-19 cases have been reported in India while 1,89,544 people have succumbed to the viral infection.

Currently, there are 25,52,940 active cases of COVID-19 in the country.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: AstrazenecaRaja krishnamoorthiAstrazeneca plc.Astrazeneca plc
Open in App

Related Stories

HealthDCGI Orders Withdrawal of AstraZeneca’s Anti-Cancer Drug Olaparib for Certain Treatments

HealthAfter Covishield, BHU Study Reveals Side Effects of Covaxin; Including Hair Loss, Skin Issues, and Menstrual Irregularities

InternationalAstraZeneca Withdraws COVID-19 Vaccine Globally Days After Side Effect Row, Firm Says Decision ‘Commercial’

NationalCovaxin-Developer Bharat Biotech Amid Reports on AstraZeneca Vaccine, Says ‘Safety Is Primary Focus for All Our Vaccines’

NationalCovishield Vaccine Side Effect: Serum Institute Faces Legal Action As Parents of Deceased Girls Prepare Lawsuit

International Realted Stories

InternationalMass deportation of Afghans from Iran and Pakistan point to urgent need for employment, aid

InternationalTrump slaps additional 25 per cent tariff on Indian imports over Russian oil purchases

InternationalSouth Korea: Special counsel to try for Yoon's detention again

InternationalLittle girl in southern Cambodia becomes 15th victim of bird flu in 2025

InternationalPakistan continues to persecute religious minorities using blasphemy laws: Report